Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma

Abstract

Purpose To report the results of ruthenium-106 plaque radiotherapy for iris malignant melanoma.

Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma

“…At our evaluation, best-corrected visual acuity of the involved eye at presentation with the suspicious conjunctival lesion was 20/20 in 2 cases, 20/30 in another and light perception (LP) in a fourth case, and median intraocular pressure (IOP) was 14mmHg (mean: 13, range: [12][13][14]. Examination of the suspicious conjunctival lesions revealed a single small (<5mm in diameter) red lesion in one case, large single multilobed pink lesion in another, and several small pigmented lesions in 2 cases.…”

Plaque radiotherapy for anterior uveal melanomas

“…В последние годы появились сведения об использовании лучевых методов лечения больных с вышеуказанной патологией [11,[13][14][15][16][17][18][19][20]. Некоторые авторы демонстрируют высокую эффективность и относительную безопасность локального облучения опухоли с использованием радиоактивных офтальмоаппликаторов.…”

Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience

“…Finger et al 18 used palladium-103 plaque therapy for iris and ciliary body melanoma and achieved 100% control. Tsimpida et al 19 and Razzaq et al 20 have demonstrated success with ruthenium-106 ( 106 Ru) plaque therapy.…”